Open AccessComparison of Different EGFR Gene Mutation Status in Patients with Metastatic Non-Small Lung Cancer After First-Line EGFR-TKIs Therapy and Analyzing Its Relationship with Efficacy and Prognosis
Author(s) -
Chengliang Yuan,
Huiqin Jiang,
Wei Jiang,
Huilin Wang,
Cuiyun Su,
Shaozhang Zhou
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s329900
Subject(s) - t790m , medicine , mutation , lung cancer , oncology , liquid biopsy , refractory (planetary science) , afatinib , cancer , epidermal growth factor receptor , gene , erlotinib , gefitinib , biology , genetics , astrobiology
The purpose of this study is to compare the different EGFR mutation status in patients with metastatic non-small cell lung cancer (NSCLC) after first-line EGFR-TKIs therapy and analyze its relationship with efficacy and prognosis.